SangoBidsSangoBids
By organisation

Bidding to: Global Fund (HIV, TB, malaria)

The Global Fund finances grants; it does not buy for countries. Grant recipients (most often a ministry of health, a central medical store or an NGO, called the Principal Recipient) do the buying, with their sub-recipients. Under the Global Fund's guide for health products, a recipient may, unless the Fund requires otherwise, use its own procurement rules, hire a procurement agent selected competitively, or use the Fund's Pooled Procurement Mechanism (PPM, the wambo.org platform). For a local firm this means identifying the recipient and its rules, more than the Fund itself.

Checked on 2 November 2026

Where to find notices

  • Information pour les fournisseurs du Fonds mondial

    The Fund keeps no list of preselected suppliers. It points to the procurement policy, product-by-product quality assurance requirements, Price & Quality Reporting registration, the PPM and wambo.org, and the supplier code of conduct. The Fund's regular tenders for medicines and diagnostics are on its 'Business & Consultancy Opportunities' page.

    Price & Quality Reporting: registration to see what grants have already bought.

  • wambo.org (plateforme d'achat en ligne du Fonds mondial)

    Platform where country procurement teams search for and track orders of health products, mainly for HIV, TB and malaria. Orders are placed through procurement service agents. It is not a portal where a small firm files bids.

    Eligible buyers only.

  • Site et appels d'offres du récipiendaire principal

    When the recipient uses its own rules, it publishes the tender: ministry of health, central medical store, NGO or grant management unit. Its notices are on its website, in the press or on the national public procurement portal. We have no single source common to all countries.

The buying methods

  • Règles d'achat propres du récipiendaire (national procurement)

    The recipient may use its own systems and procedures unless the Fund decides otherwise. The Fund's principles still apply: value for money, competition 'to the maximum practical extent', transparency, and compliance with the code of conduct. Also read the country guide, as national rules apply.[1]

  • Agent d'approvisionnement (procurement service agent)

    The recipient may hire a local, regional or international agent selected competitively. Under the PPM, all current wambo.org orders are placed through procurement service agents. It has no direct national equivalent.[1][3][2]

  • PPM (Pooled Procurement Mechanism) / wambo.org

    The Fund's pooled purchasing mechanism, which negotiates prices on behalf of recipients. Optional in principle, but the Fund can require it for a recipient whose procurement capacity it judges insufficient. It has no direct national equivalent.[1][3]

  • Global Drug Facility (médicaments contre la tuberculose multirésistante)

    All purchases of multidrug-resistant TB medicines must go through a designated procurement agent of the Global Drug Facility. A local firm cannot supply them directly.[1]

Being eligible, qualified and registered

To sell health products on these funds, your product must meet quality requirements before your price matters. Start with the Fund's list of compliant products.

  • The Fund keeps no list of preselected suppliers. It recommends reading the procurement policy, learning the quality assurance requirements of each product, registering for Price & Quality Reporting (to see what grants have already bought), understanding the PPM and wambo.org, and reading the supplier code of conduct.[3]
  • All purchases must comply with the Global Fund's supplier code of conduct and recipient code of conduct (guide, 2.7 v). The supplier code of conduct is available in French.[1][4]
  • HIV, malaria and TB medicines must, in addition to national requirements, be WHO-prequalified, or authorised by a stringent regulatory authority, or permitted for time-limited purchase after Expert Review Panel review (guide, 4.5). For uncomplicated malaria, only fixed-dose combinations are bought once at least two compliant products are notified available (4.4).[1]
  • Diagnostic products: the manufacturing site must meet ISO 13485 (in vitro diagnostics and imaging) or the ISO 9000 series (other products). The manufacturer and site must be disclosed in all tender documents. Tests for HIV, TB, malaria, hepatitis B and C and syphilis must also have WHO prequalification, or authorisation by a founding-member authority of the GHTF, or Fund acceptance on Expert Review Panel advice (guide, 5.10 to 5.12).[1]
  • The Fund maintains lists on its website, updated monthly for medicines, of products it knows to be compliant. The lists are indicative and non-exhaustive (guide, 4.6 and 5.13).[1]

Finding purchases

  • Three purchasing routes exist for a recipient: joining the Fund's PPM, commissioning a procurement service agency, or buying directly through its own procurement services (Fund procurement tools page).[2]
  • Responsibility for carrying out the programme and awarding contracts rests with the recipient. It may impose certain obligations on its sub-recipients, agents and manufacturers, which must comply with the guide and incorporate its provisions. The recipient stays accountable for compliance (guide, 1.2).[1]
  • The Fund's regular tenders for medicines and diagnostics are on its 'Business & Consultancy Opportunities' page. Past tenders are listed on each product category page.[3]

Preparing the bid

Your price is judged against the Fund's global reference price. Before bidding, compare yourself with the prices published in Price & Quality Reporting.

  • The Fund will not finance a health product bought at a price above the reference price, where one exists. This reference price comes from price lists negotiated by the Fund or its partners (guide, 2.7 i).[1]
  • Recipients must use transparent and competitive procedures. The Fund does not accept national or domestic preference in procurement decisions, unless mandatory under applicable laws (guide, 2.9).[1]
  • Procurement is competitive to the maximum practical extent, impartial, transparent and accountable. The Fund can approve purchases with no or restricted competition in limited cases, for example certain diagnostics after Fund approval (guide, 2.7 and 5.20).[1]

Evaluation

  • For diagnostics, the recipient runs a competitive process to award contracts, taking into account total cost of ownership, including training and validation of new diagnostic algorithms (guide, 5.19).[1]
  • The recipient must monitor the performance of contractors, agents, manufacturers and sub-recipients and give the Fund all contract documents for each transaction on request (guide, 2.11 and 2.12).[1]

Complaining and reporting

  • The Fund's site has a 'Report Fraud & Abuse' link for reporting fraud or abuse. We found no Fund complaint procedure aimed at bidders unsuccessful with a recipient.[4]
  • In case of non-compliance with the guide, the Fund reserves the right to exercise the remedies in the grant agreement. The guide is incorporated by reference into that agreement (guide, 1.1 and 1.4).[1]

Traps to know about

  • Do not expect a preference because you are local. The Fund does not accept domestic preference in procurement, unless a law of the country requires it. Your edge is proximity, delivery and service, not status.
  • Where a reference price exists, the Fund does not finance a product bought at a higher price. If your margin puts you above it, the recipient cannot buy from you with these funds.
  • HIV, malaria and TB medicines and most diagnostics must meet specific quality standards (WHO prequalification, stringent-authority authorisation or Expert Review Panel opinion). A small firm that does not manufacture must check that its supplier's product and manufacturing site comply before bidding.
  • The Fund can require the PPM for a recipient with insufficient procurement capacity. In that case, according to the Fund's supplier page, orders go through procurement service agents rather than an ordinary local tender.

What we could not confirm

Rather than guess, we list here what no reliable source allowed us to confirm. On these points, rely on the tender file or ask the body concerned.

  • The guide read is dated June 2021 and covers health products only. The Fund lists a Procurement Policy and newer quality assurance policies (November 2023, April 2024), with no date for the first. We do not know whether a newer version of the guide exists.
  • Not established: the rules for recipients' purchases other than health products (works, vehicles, services, consulting), procurement rules specific to NGO or ministry recipients, and the Fund's list of sanctioned suppliers. The guide does not cover them. Each recipient applies its own rules, often the national code.
  • We could not open the operational policy note on the PPM or the 'Business & Consultancy Opportunities' page. The exact conditions under which the Fund requires the PPM, and how a local supplier can become a subcontractor of a procurement agent, are therefore not described.

Sources

  1. Guide to Global Fund Policies on Procurement and Supply Management of Health Products (June 2021) (The Global Fund, 2021-06)
  2. Procurement tools (PPM, wambo.org, procurement service agencies) (The Global Fund)
  3. Information for suppliers (The Global Fund)
  4. Sourcing and management of health products (policies, codes of conduct, report fraud) (The Global Fund)

Read next

Ready to try?

The account is free and public tenders stay free. Three minutes is enough to receive the first ones.

Get started free